Baxter International disclosed 2024 pay packages for former Chair, President and CEO José Almeida, other top execs and its ...

Eton Pharmaceuticals (ETON) stock in focus as the company out-licenses overseas rights for its hormone disorder therapy ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

SkyWater Technology , the trusted technology realization partner, today announced the appointment of three accomplished professionals to its board of directors: Timothy E. Baxter, Tammy J. Miller and ...

Eton Pharmaceuticals (ETON) announced the out-licensing of commercial rights to Increlex in territories outside of the U.S. to Esteve ...

Baxter International Inc. (NYSE:BAX – Get Free Report) has earned an average rating of “Hold” from the ten research firms that are currently covering the company, Marketbeat.com reports. One analyst ...

Dziubinski: All right, we’ve arrived at everyone’s favorite part of the show: this week’s stock picks. Now these three stocks ...

Baxter International Inc.'s $4.3 billion retirement plan is plagued by a poorly performing stable value fund that carries ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Illumina (ILMN – Research Report) and Arcellx ...

The Business Research Company Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout. LONDON, GREATER ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...